Cargando…

Monoamino-oxidase-A function and potential benefit of its inhibition in sepsis

Detalles Bibliográficos
Autores principales:	Otto, GP, Sossdorf, M, Lemm, J, Scholz, S, Claus, RA, Bauer, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254962/ http://dx.doi.org/10.1186/cc9147

Ejemplares similares

System biology of multiple organ dysfunction: formation of a ceramide-enriched macro-domain in SIRS/sepsis
por: Suckert, I, et al.
Publicado: (2010)

Monoamino oxidase alleles correlate with the presence of essential hypertension among hypogonadic patients
por: Royo, José Luis, et al.
Publicado: (2019)

Transcripts coding the VWF cleaving protease are decreased under proinflammatory conditions, which is reversed by co-incubation with activated protein C and selenate
por: Conradi, F, et al.
Publicado: (2010)

Effects of Monoamino-Oxidase-A (MAO-A) Inhibition on Skeletal Muscle Inflammation and Wasting through Pancreatic Ductal Adenocarcinoma in Triple Transgenic Mice
por: Schmich, Simon K. P., et al.
Publicado: (2023)

Monoamino Oxidase A Gene Single-Nucleotide Polymorphisms and Methylation Status and the Risk of Violent Suicide Attempts in Affective Disorder Patients
por: Ludwig, Birgit, et al.
Publicado: (2021)

Continuous flow synthesis of 6-monoamino-6-monodeoxy-β-cyclodextrin
por: Orosz, János Máté, et al.
Publicado: (2023)

Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis
por: Otto, Gordon P, et al.
Publicado: (2013)

Highly Soluble Monoamino-Substituted Perylene Tetracarboxylic Dianhydrides: Synthesis, Optical and Electrochemical Properties
por: Chen, Kew-Yu, et al.
Publicado: (2014)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
por: Yamakawa, K, et al.
Publicado: (2014)

Risk/benefit analysis of activated protein C in patients with intra-abdominal sepsis
por: Borthwick, E, et al.
Publicado: (2007)

Pharmacologic inhibition of cholinesterase improves survival in experimental sepsis
por: Hofer, S, et al.
Publicado: (2007)

The late phase of sepsis is characterized by an increased microbiological burden and death rate
por: Otto, Gordon P, et al.
Publicado: (2011)

Prevalence of vitamin D deficiency among children with sepsis, its association with sepsis severity and its outcome in a pediatric ICU
por: Satheesh, Ponnarmeni, et al.
Publicado: (2013)

Complement factor D is linked to platelet activation in human and rodent sepsis
por: Sommerfeld, O., et al.
Publicado: (2021)

BNP and NT-proBNP in patients with acute myocardial infarction complicated by cardiogenic shock: results from the IABP Shock trial
por: Lemm, H, et al.
Publicado: (2010)

In vivo leukocyte–endothelium interactions in rat mesenteric microvessels after ischemia/reperfusion and sepsis
por: Nakagawa, NK, et al.
Publicado: (2005)

Treatment of sepsis: a systematic review of its main concepts
por: Santana, Jéssica, et al.
Publicado: (2013)

Potential role of “the compensating benefit” in claiming non-inferiority
por: Beryl, Primrose, et al.
Publicado: (2013)

Forty percent of hospitalizations after severe sepsis are potentially preventable
por: Prescott, HC, et al.
Publicado: (2014)

Sphingosine-1-phosphate is a novel biomarker in sepsis severity
por: Nierhaus, A, et al.
Publicado: (2015)

An epidemiological study of sepsis in ICUs: Sepsis Brazil Study
por: Sales, J, et al.
Publicado: (2006)

Sphingosine-1-phosphate is a new biomarker for severity in human sepsis
por: Winkler, MS, et al.
Publicado: (2015)

A limited set of molecular biomarkers may provide superior diagnostic outcomes to procalcitonin in sepsis
por: Brandon, RB, et al.
Publicado: (2012)

Differential diagnosis of systemic inflammatory response syndrome versus sepsis based on a multiplex quantitative PCR assay
por: Kortgen, A, et al.
Publicado: (2009)

Costs of severe sepsis according to the guidelines of the 'Surviving Sepsis Campaign'
por: de Anda, G Vazquez, et al.
Publicado: (2005)

IL-33 protects mice from sepsis by inhibiting TLR4 signaling
por: Alves-Filho, JC, et al.
Publicado: (2009)

Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
por: Prucha, M, et al.
Publicado: (2005)

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, Lars, et al.
Publicado: (2008)

The role of CC-chemokine receptor 4 in murine polymicrobial sepsis
por: Maier, Stefan, et al.
Publicado: (2007)

Mitochondrial injury in sepsis
por: Nogueira, AC, et al.
Publicado: (2007)

Alpha-1 antitrypsin regulates neutrophil reactive oxygen species production via inhibition of key players of the respiratory burst oxidase system
por: Alfawaz, Bader, et al.
Publicado: (2013)

Benefit of achieving lactate clearance versus central venous oxygen saturation target as microcirculation end point resuscitation in severe sepsis and septic shock
por: Sinto, R, et al.
Publicado: (2014)

Subgroup analysis of the lipid infusion and patient outcomes in sepsis trial (LIPOS) reveals benefit in a subgroup not treated with stress replacement doses of corticosteroids
por: Parker, TS, et al.
Publicado: (2014)

Nitroxyl, the novel redox sibling of NO, suppresses cerebrovascular NADPH oxidase
por: Kemp-Harper, Barbara, et al.
Publicado: (2009)

A proteomic study of sepsis
por: Soares, A, et al.
Publicado: (2005)

Prevention of sepsis by correcting apoptosis
por: Puhtinskaya, M, et al.
Publicado: (2013)

Epidemiology of severe sepsis in India
por: Todi, S, et al.
Publicado: (2007)

Modelling immune responses in sepsis
por: Grealy, R, et al.
Publicado: (2012)

Sepsis: a study of physician's knowledge about the Surviving Sepsis Campaign in Puerto Rico
por: Fernandez, R, et al.
Publicado: (2006)

Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation
por: Ekaney, Michael Liembo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qbkes50tml1d1r73ejbt8dcdkq